Legend Biotech Corp (LEGN) Gains from Investment Securities (2019 - 2025)

Legend Biotech (LEGN) has reported Gains from Investment Securities for 7 consecutive years, with -$877000.0 the latest figure, recorded in Q3 2025.

• Gains from Investment Securities for Q3 2025 came in at -$877000.0, down 101.42% year-over-year; the trailing twelve-month figure through Sep 2025 was $59.0 million (up 1.24% YoY), and the FY2021 annual result was $688.9 million, up 51.19% from the prior year.
• Gains from Investment Securities was -$877000.0 for Q3 2025 at Legend Biotech, up from -$1.3 million in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $412.3 million in Q1 2021 and troughed at -$412.8 million in Q2 2021.
• Average Gains from Investment Securities over 5 years is $22.7 million, with a median of -$877000.0 recorded in 2025.
• Year-over-year, Gains from Investment Securities tumbled 173.41% in 2021 and surged 3696.86% in 2024.
• Over 5 years, Gains from Investment Securities stood at -$1.4 million in 2021, then slumped by 82.95% to -$2.6 million in 2022, then soared by 33.71% to -$1.7 million in 2023, then soared by 3696.86% to $61.9 million in 2024, then slumped by 101.42% to -$877000.0 in 2025.
• Per Business Quant data, the three most recent Gains from Investment Securities figures were -$877000.0 in Q3 2025, -$1.3 million in Q2 2025, and -$777000.0 in Q1 2025.